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PPRECLINICAL STUDY
Extracellular Superoxide Dismutase
Accelerates Endothelial Recovery and Inhibits
In-Stent Restenosis in Stented Atherosclerotic
Watanabe Heritable Hyperlipidemic Rabbit Aorta
Jan Hinrich Bräsen, MD,*† Olli Leppänen, MD,*‡ Matias Inkala, MD,* Tommi Heikura, MSC,*
Max Levin, MD, PHD,§ Fabian Ahrens, MSC, Juha Rutanen, MD, PHD,* Hubertus Pietsch, DVM,¶
David Bergqvist, MD, PHD,‡ Anna-Liisa Levonen, MD, PHD,* Samar Basu, PHD,‡
Thomas Zeller, MD, FESC,** Günter Klöppel, MD,† Mikko O. Laukkanen, PHD,††
Seppo Ylä-Herttuala, MD, PHD, FESC*‡‡
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and Berlin and Bad Krozingen, Germany
Objectives This study examined whether local gene therapy with extracellular superoxide dismutase (EC-SOD) could inhibit
in-stent restenosis in atherosclerotic Watanabe heritable hyperlipidemic rabbits.
Background Stenting causes an acute increase in superoxide anion production and oxidative stress; EC-SOD is a major component
of antioxidative defense in blood vessels and has powerful cardioprotective effects in ischemic myocardium.
Methods Endothelial denudation and stenting were done in 36 adult (15 to 18 months old) rabbits. Catheter-mediated
intramural delivery of clinical good manufacturing practice-grade adenoviruses encoding rabbit EC-SOD were
done simultaneously with stenting. Control animals received adenovirus-encoding nuclear-targeted
-galactosidase (AdLacZ). Circulating markers for oxidative stress (nonesterified 8-iso-prostaglandin F2 alpha)
were measured. Analysis of 6-day, 28-day, and 90-day vessel histology, radical production, oxidation-specific
epitopes, and expression studies were performed.
Results The EC-SOD treatment reduced oxidant production in stented vessels compared with control vessels. Early sys-
temic recovery of total SOD activity was observed in the treated rabbits. The EC-SOD significantly accelerated
endothelial recovery (67.4%  10.8% vs. 24.2.1%  4.6% at 6 days, p  0.05; 89.3%  3.7% vs. 45.1% 
9.6% at 28 days, p  0.05), and the beneficial effect involved increased proliferation of regenerating endothe-
lium. The EC-SOD group showed a 61.3% lower (p  0.05) neointimal formation at 28 days, with a similar,
albeit nonsignificant trend at 90 days (1.20  0.32 mm2 vs. 1.88  0.24 mm2, p  0.06).
Conclusions The results suggest a central pathogenetic role of oxidation sensitive signaling processes in endothelial recovery
and developing in-stent restenosis in atherosclerotic vessels. Local therapy against oxidative stress represents a
promising therapeutic strategy in stent-induced vascular injury. (J Am Coll Cardiol 2007;50:2249–53) © 2007
by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.08.038d
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educed target lesion revascularization rates but interfere
ith endothelial integrity (1), demanding further research
or complementary therapies (2). Balloon angioplasty in-
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ocal superoxide anion (O2
) generation (5), and decreased
ascular superoxide dismutase (SOD) activity (6–7). Vas-
ular trauma imposed by struts and prolonged arterial strain
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EC-SOD and ISR December 4, 2007:2249–53initiates a repair process that is
distinct from ballon injury (1),
and may impose additional ox-
idative burden that can be
chronic (8).
Extracellular superoxide dis-
mutase (EC-SOD) is a major
component of antioxidative de-
fense in blood vessels (9), and
exogenously delivered EC-SOD
protects against balloon-induced
neointima formation (6) and
constrictive remodeling (7) and
has powerful cardioprotective
properties (10).
The aim of this study was to
test whether local EC-SOD de-
ivery has beneficial effects on stent-induced vascular
rauma. We used an established Watanabe heritable hyper-
ipidemic (WHHL) rabbit model (11), in which atheroscle-
osis closely mimics human disease (12). It was found that
C-SOD reduced tissue oxidant production, attenuated
eveloping in-stent restenosis (ISR), and accelerated endo-
helial regrowth.
ethods
he study was approved by the University of Kuopio
esearch Animal Ethics Committee and conforms to Na-
ional Institutes of Health guidelines. Adult WHHL rab-
its (n  36) received daily aspirin and clopidogrel, were
ept on standard diet, and were randomized to 6 groups
Table 1).
Three days after aortic denudation (13), the rabbits were
eparinized and a bare-metal stent (approximately 1.0:1 to
:1 stent-to-artery ratio, 3.0  18 mm, approximately 9
tm, Guidant Multi-Link, Guidant Corporation, Santa
lara, California) was implanted to an infrarenal aortic
egment free of side branches. Infusion of adenoviruses
Abbreviations
and Acronyms
DHE  dihydroethidium
EC-SOD  extracellular
superoxide dismutase
HOCl  hypochlorite
ISR  in-stent restenosis
ONOO  peroxynitrite
PGF2  prostaglandin F2
alpha
SMC  smooth muscle cell
SOD  superoxide
dismutase
WHHL  Watanabe
heritable hyperlipidemic
orphometry, Animal Weights, and Blood Analyses
Table 1 Morphometry, Animal Weights, and Blood Analyses
n at End Point
Treatment (Ad)
Baseline
(14 Days)
30 Min
Post-Stenting
LacZ EC-SOD LacZ EC-SOD
Total vessel area, mm2 NA NA NA NA
Injury score, 0 to 4 NA NA NA NA
Weight, kg 3.3 0.2 3.0 0.2 NA NA
Cholesterol, mmol/l 11.9 1.0 12.1 0.9 NA NA
Triglycerides, mmol/l 3.8 0.5 4.4 1.0 NA NA
SOD activity, inhibition rate % 74.6 0.5 75.6 0.7 65.0 1.0 63.8 1One of 5 rabbits was found hemiparetic at 59 days and was excluded. Autopsy revealed acute thromboe
Ad  adenovirus; EC-SOD  extracellular superoxide dismutase; LacZ  -galactosidase control; NA ncoding rabbit extracellular superoxide dismutase (AdEC-
OD) or control adenovirus-encoding nuclear-targeted
-galactosidase (AdLacZ) (1.15  1010 plaque-forming
nits in 2.0 ml saline over 2 min) was performed to the
tented segment via injection ports of Infiltrator drug
elivery catheter (Boston Scientific, Natick, Massachusetts).
nstrumentations and euthanasia were performed using
uanisone/fentanyl and midazolam anesthesia.
denoviruses. Replication-deficient E1-partially E3-
eleted clinical good manufacturing practice-grade adeno-
iruses encoding nuclear-targeted -galactosidase (LacZ) or
abbit EC-SOD were produced (6) and tested to be free
rom contaminants (14).
lood sampling and autopsy. Blood was collected at
ntervals for nonesterified 8-iso-prostaglandin F2 alpha
PGF2), a biomarker of oxidative stress (15); circulating
otal SOD (Dojindo Laboratories, Kumamoto, Japan); and
asic clinical chemistry parameters (13). Eighteen animals
3 per group) underwent veterinary autopsy (13).
issue analysis. The 28- and 90-day vessels, the proximal
wo-thirds of the stented vessel from 6-day animals, and all
roximal and distal (2 cm from stent edges) reference
egments were immersion-fixed in formalin (8). The distal
ne-third (6-day animals) was snap-frozen in liquid nitro-
en and further processed for reverse transcriptase–
olymerase chain reaction of transduced EC-SOD mRNA
nd dihydroethidium (DHE) staining (6) after removal of
truts.
The formalin-fixed samples were sectioned (5-m
ections, 4 to 6 per animal, 4 mm apart) (Fig. 1A) and
tained (8). Immunohistochemistry was performed with
onoclonal antibodies (mAbs) against endothelium (plate-
et endothelial cell adhesion molecule-1 [PECAM-1], 1:50,
anta Cruz Biotechnology, Santa Cruz, California), rabbit
acrophages (RAM 11 mAb, 1:50, DAKO A/S, Glostrup,
enmark), muscle-specific actin (HHF35 mAb, 1:50,
AKO A/S), -galactosidase (anti- Gal mAb, 1:50,
romega, Madison, Wisconsin), proliferating cell expres-
ion Ki-67 nuclear protein (Mib-1 mAb, 1:50, DAKO
End Point
6 Days 28 Days 90 Days
5 5 8 8 4* 5
LacZ EC-SOD LacZ EC-SOD LacZ EC-SOD
6.0 0.6 17.7 1.0 14.3 1.6 14.2 1.4 16.5 1.5 15.9 1.0
2.1 0.2 2.3 0.3 2.0 0.1 2.2 0.3 2.1 0.2 2.1 0.1
3.2 0.2 3.1 0.3 3.4 0.3 3.3 0.2 3.4 0.4 3.5 0.2
2.8 1.1 12.0 0.9 13.6 1.7 10.8 0.7 12.3 1.6 13.1 1.5
3.2 0.7 3.5 0.8 3.3 0.3 6.0 1.0 4.2 0.9 3.8 0.6
9.5 2.6 80.6 2.0† 72.3 2.0 74.8 1.4 76.2 0.7 75.9 0.41
1
.0 6mbolic cerebrovascular occlusion. †p  0.01 versus 6-day AdLacZ; for other comparisons p NS.
not applicable; SOD  superoxide dismutase.
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December 4, 2007:2249–53 EC-SOD and ISR/S), peroxynitrite (ONOO)-modified epitopes (a poly-
lonal antibody against 3-nitrotyrosine, 1:50, Upstate Bio-
echnology, Lake Placid, New York), and hypochlorite
HOCl)-modified proteins (mAb clones 2D10G9 and
E10E11, 1:20, a generous gift from Dr. E. Malle, Inns-
ruck, Austria). Apoptotic nuclei were assessed with a
dT-mediated dUTP-biotin nick end-labelling (TUNEL)
it (R&D, Minneapolis, Minnesota).
Digitized histomorphometry, macrophage and endothe-
ial cells counts, and a modified (0 to 4) Schwartz injury
core were determined. The mean value from all serial
egments was calculated and used for statistical analysis.
tent edges were not analyzed. All measurements were
erformed blinded (F.A., J.H.B.).
tatistics. Analysis of variance or nonparametric Kruskal-
allis tests and t test were used as appropriate. The
onferroni correction was used when necessary. All data
epresent mean  standard error. Differences in the results
ere considered statistically significant at p  0.05.
esults
C-SOD inhibits ISR. The lesions had structural features
imilar to human plaques subjected to percutaneous coro-
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Figure 1 Quantification of In-Stent Restenosis
(A) Micro-computed tomographic imaging, methacrylate embedding (insert), and s
dissection. Bar  1 mm. (C) Strut overlying atherosclerotic lesion. (D) Histomorph
sections. Arrowheads indicate IEL. Bars  100 m; AdEC-SOD  adenovirus-enco
nuclear targeted -galactosidase; IEL  ifernal elastic lamina; m  media; NS ary intervention (8) (Figs. 1B and 1C). At 6 days no cifferences in ISR were detected. As compared with 6-day
ontrol animals, the neointima size in 28-day control
nimals was 2.6-fold (p  0.05) larger. At this principal
8-day end point (16), the EC-SOD rabbits had a 61.3%
ower neointima than control animals (p  0.05), with a
onsignificant trend at 90 days (1.20  0.32 mm2 vs. 1.88 
.24 mm2, p  0.06) (Fig. 1D). At 6 days, the apoptosis rate
as higher in neointimal SMCs in EC-SOD animals versus
-day control animals (6.8  0.9% vs. 3.7  0.4% in control
nimals, p  0.01). No differences between the treat-
ents were observed in SMC proliferation or apoptosis
ates at other time points or vessel layers (data not
hown).
No differences were observed in injury score, body
eights, blood lipids (Table 1), the other wall areas (Fig.
D, Table 1), clinical chemistry, or lesion formation in
e-endothelialized but unstented segments (data not
hown). No signs of toxicity were detected (data not
hown).
C-SOD accelerates re-endothelialization. The EC-
OD animals showed higher re-endothelialization rates at 6
ays and 28 days. At 90 days, both groups were 90%
ndothelialized (Fig. 2A). At 6 days, endothelial cell pro-
iferation was higher in EC-SOD rabbits versus 6-day
s
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ections. (B) Quantification of vessel compartments. Arrow indicates medial
y. *p  0.05. (E) Representative images of Mason trichrome-stained 28-day
abbit extracellular superoxide dismutase; AdLacZ  control adenovirus encoding
nificant; s  strut.P=NS
P=N
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EC-SOD and ISR December 4, 2007:2249–53o effects were seen at 28 days (4.5%  1.4% vs. 4.1% 
.2% in control animals, p NS), and at 90 days only a few
roliferating (Ki-67 immunopositive) nuclei were detected
pNS, data not shown). Macrophages (Fig. 2B) or matrix
ccumulation (6 days: 47%  12% of vessel wall area within
xternal elastic lamina in EC-SOD rabbits vs. 43% 9% in
ontrol animals, p  NS; 28 days: 65  12% vs. 76  16%,
 NS; 90 days: 74 17% vs. 82 21%, p NS) did not
iffer among the groups.
C-SOD reduces oxidative stress. In EC-SOD rabbits, a
eduction in oxidant production was seen in areas where the
ransgene expression was detected primarily in SMCs, by
-gal staining (a chromogen [5-brom-4-chlor-3-indoxyl--
-galactopyranoside] substrate for -galactosidase) and
onoclonal antibody against -galactosidase. The EC-SOD
ransgene expression was demonstrated at the mRNA level
Fig. 2C). Staining for ONOO modified epitopes was found
o be colocalized with DHE labeling, whereas HOCl-
odified epitopes were primarily detected more deeply,
n macrophage-rich areas (Fig. 2B). Morphometrically
etermined immunostained areas of ONOO and HOCl
pitopes did not differ among the groups (data not
hown).
The intravascular manipulations caused transient ap-
roximately 2-fold increases in 8-iso-PGF2 (p  0.05
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Figure 2 Re-Endothelialization, Macrophages, Transgene Expre
(A) Endothelial coverage. (B) Neointimal macrophages. (C) LacZ transduced vess
dismutase (EC-SOD) mRNA. EC-SOD  6-day EC-SOD–stented vessel; LacZ  6-da
(ONOO)-modified epitopes. Representative images. Arrowheads  IEL. Bars  1
dismutase; Anti--gal-mAB  immunohistochemical statin with monoclonal antibod
galactosidase; mAb 2D 10G9  monoclonal antibody against hypochlorite modifie
platelet endothelial cell adhesion molecule-1; Pos.  extracellular superoxide dism
strate for -galactosidase; other abbreviations as in Figure 1.s. baseline in both groups) (Fig. 3). In EC-SODnimals, faster normalization of the values (Fig. 3) and
ecovery in the circulating SOD activity were detected
Table 1).
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December 4, 2007:2249–53 EC-SOD and ISRiscussion
he EC-SOD had significant beneficial effects on endothe-
ial recovery and attenuation of ISR. Treated rabbits had a
1.3% lower neointimal area than control animals at the
rincipal 28-day end point (16). Although no intervention
gainst the acute (24 h) increase in stenting-associated
xidative stress (3) could be obtained using the current study
esign (simultaneous delivery of gene therapy vectors and
tenting), the treatment had important beneficial effects on
ormalization of circulating F2-isoprostanes and total SOD
ctivity, suppressed further generation of tissue oxidants,
nd attenuated lesion growth. Our observations with stents
re well in line with those of Szöcs et al. (5) regarding the
mportance of SMC-derived O2
 during the first 15 days
fter injury.
Although a trend (p  0.06) toward a 36.2% lower
eointima at 90 days in the EC-SOD group was seen,
ong-term efficacy remains unknown. The failure of several
ystemic antioxidants in clinical studies, the relatively nar-
ow therapeutic index of adenoviruses, and the potential
ccumulation to nontarget organs (in case of delivery failure)
re important concerns for human applications. These issues
arrant further study and assessment before initiation of
linical trials.
The most striking feature of this study was the rapid
e-endothelialization in the EC-SOD rabbits, which
pparently contributed to the beneficial effects. The fact
hat ONOO-modified epitopes and the area of reduced
xidant production were colocalized suggests an in-
reased bioactivity of nitric oxide near the lumen after
C-SOD delivery. More importantly, the absence of
ifferences in arterial oxidation epitopes in relation to
eointima area, despite reduced lesion formation, sug-
ests an important pathophysiological role for intracellu-
ar oxidation-sensitive signaling pathways in developing
eointima and ISR.
In conclusion, our study shows that local EC-SOD
elivery by clinical-grade adenoviruses accelerates re-
ndothelialization and attenuates developing ISR in
HHL rabbits. Local therapy against oxidative stress
epresents a promising therapeutic strategy against stent-
nduced vascular injury in atherosclerotic arteries.
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